ACT vs BRK-B

ACT's Piotroski F-Score of 4/9 indicates weak financial health, signaling potential operational inefficiencies despite strong profitability. The absence of an Altman Z-Score raises concern about default risk, especially given the sector's average debt levels. While the company trades below its Graham Number ($61.88) and intrinsic value ($133.34), its current price of $40.49 reflects a significant discount, likely due to low growth and weak financial stability signals. Insider selling activity over the past six months adds bearish sentiment, and analyst consensus remains at 'hold' with limited upside. The stock's strong historical earnings surprises and high margins are offset by stagnant revenue growth and elevated peer P/E multiples.

The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.